The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, China.
Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, 200030, China.
J Sex Med. 2023 Oct 31;20(11):1325-1332. doi: 10.1093/jsxmed/qdad117.
Previous research has documented the impact of the COVID-19 pandemic on male sexual and mental health. However, no prior study has evaluated the efficacy of online cognitive behavioral therapy (CBT) during the COVID-19 pandemic for treating nonorganic erectile dysfunction (ED) by improving negative emotions and self-esteem.
To test the efficacy of online CBT for nonorganic ED during the COVID-19 pandemic in Shanghai, China.
A randomized controlled trial was conducted during the COVID-19 pandemic. Paired t-tests and 1-way analysis of variance were used to analyze and compare erectile functioning, self-esteem, and emotional state between and within groups.
The main outcome measures included scores on the 5-item International Index of Erectile Function, Rosenberg Self-esteem Scale, 9-item Patient Health Questionnaire, and 7-item Generalized Anxiety Disorder scale to evaluate erectile functioning, self-esteem, depression, and anxiety, respectively.
In the CBT group, erectile functioning, intercourse satisfaction, orgasmic functioning, sexual desire, and overall satisfaction were significantly improved at posttreatment as compared with pretreatment (P < .05). After treatment, group differences in emotional state and self-esteem were observed between the CBT group and the control group. Results revealed that the CBT group had significantly better scores than the control group at posttreatment on the Rosenberg Self-esteem Scale (mean ± SD, 30.43 ± 6.51 vs 22.67 ± 10.74), Patient Health Questionnaire (7.07 ± 2.74 vs 11.07 ± 4.41), and Generalized Anxiety Disorder scale (8.36 ± 1.97 vs 11.13 ± 3.94; P < .05).
This study represents an important advance in understanding of the efficacy of online CBT for treating nonorganic ED in reproductive-age males during the COVID-19 pandemic.
The study participants, treatment modality, and COVID-19 pandemic background of this study are innovative and therefore strengths. However, our study has several limitations-namely, its sample size and use of self-report data to measure erectile functioning due to the pandemic. Further studies should incorporate sexual functioning-monitoring instruments as well as self-report data to measure erectile function.
Online CBT clearly improved the emotional state and self-esteem of patients with ED during the COVID-19 pandemic.
先前的研究记录了 COVID-19 大流行对男性性健康和心理健康的影响。然而，先前没有研究评估过在 COVID-19 大流行期间，在线认知行为疗法（CBT）治疗非器质性勃起功能障碍（ED）的疗效，即通过改善负面情绪和自尊心来治疗非器质性 ED。
在中国上海，测试在线 CBT 在 COVID-19 大流行期间治疗非器质性 ED 的疗效。
在 COVID-19 大流行期间进行了一项随机对照试验。采用配对 t 检验和单因素方差分析对组内和组间的勃起功能、自尊心和情绪状态进行分析和比较。
主要结局指标包括 5 项国际勃起功能指数、罗森伯格自尊量表、9 项患者健康问卷和 7 项广泛性焦虑障碍量表的评分，分别评估勃起功能、自尊心、抑郁和焦虑。
与治疗前相比，CBT 组在治疗后，勃起功能、性交满意度、性高潮功能、性欲和整体满意度均显著改善（P<0.05）。治疗后，CBT 组与对照组在情绪状态和自尊心方面存在组间差异。结果显示，CBT 组在治疗后罗森伯格自尊量表（均数±标准差，30.43±6.51 对 22.67±10.74）、患者健康问卷（7.07±2.74 对 11.07±4.41）和广泛性焦虑障碍量表（8.36±1.97 对 11.13±3.94）的评分明显优于对照组（P<0.05）。
本研究代表了对在线 CBT 在 COVID-19 大流行期间治疗生殖年龄男性非器质性 ED 疗效的重要理解进展。
本研究参与者、治疗方式和 COVID-19 大流行背景具有创新性，因此是本研究的优势。然而，本研究也存在一些局限性，即由于疫情原因，样本量较小，且使用自我报告数据来测量勃起功能。未来的研究应纳入性功能监测工具以及自我报告数据来测量勃起功能。
在线 CBT 明显改善了 COVID-19 大流行期间 ED 患者的情绪状态和自尊心。
